Publicaciones en colaboración con investigadores/as de Tel Aviv University (7)

2024

  1. Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM

    Journal of the American Heart Association, Vol. 13, Núm. 15, pp. e035993

  2. Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM

    Journal of the American College of Cardiology, Vol. 84, Núm. 19, pp. 1821-1831

2023

  1. Ventricular arrhythmias in patients with hypertrophic cardiomyopathy: Prevalence, distribution, predictors, and outcome

    Heart Rhythm, Vol. 20, Núm. 10, pp. 1385-1392

2022

  1. Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2301-2312

2019

  1. The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy

    European Heart Journal, Vol. 40, Núm. 21, pp. 1671-1677

2016

  1. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies

    Journal of the American College of Cardiology, Vol. 68, Núm. 22, pp. 2440-2451

2015

  1. Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain

    Heart, Vol. 101, Núm. 13, pp. 1047-1053